This is a ClearView 3 Multifocal implant 45 minutes post-implantation. The IOL centers perfectly, and the eye is quiet. As you can see, the ClearView 3, unlike all other multifocal IOL implants, has minimal transition zones. This equates to patients having excellent distance, intermediate and near vision almost immediately following implantation, and minimal visual side effects.Read More
“Patients have reported high levels of satisfaction with minimal side effects. I believe the ClearView will be an excellent option for refractive lens surgeons to offer their patients seeking their best vision and independence from glasses after cataract surgery. No patients in the study reported negative dysphotopsia and reported a 94% rate of spectacle independence.”…Read More
Lenstec Inc has announced that it has rebranded its new multifocal IOL, the SBL-3, to the ClearView™ 3. The IOL was approved by the FDA in July of 2022. The rebrand occurred to better describe the vision patients can expect with the new IOL. Since approval, the ClearView 3 has been used by many surgeons…Read More
Become a ClearView 3 Surgeon
Contact the Lenstec team to find out how you can become a ClearView 3 Surgeon to help your patients improve their vision. ClearView 3 surgeons will be featured on our Surgeon Finder.